Emerald Advisers, LLC Ocular Therapeutix, Inc Transaction History

Emerald Advisers, LLC

$2.01 Billion
Q1 2025

A detailed history of Emerald Advisers, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Emerald Advisers, LLC holds 20,768 shares of OCUL stock, worth $166,351. This represents 0.01% of its overall portfolio holdings.

Number of Shares

20,768

Previous 20,768 -0.0%

Holding current value

$166,351

Previous $177,000 14.12%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	SELL	$3.14 - $5.04 $78,339 - $125,742	-24,949 Reduced 54.57%	20,768 $65,000
Q1 2023 May 04, 2023	SELL	$2.79 - $6.27 $2.57 Million - $5.77 Million	-919,524 Reduced 95.26%	45,717 $240,000
Q4 2022 Feb 03, 2023	SELL	$2.61 - $4.41 $1.41 Million - $2.39 Million	-541,215 Reduced 35.93%	965,241 $2.71 Million
Q3 2022 Oct 25, 2022	BUY	$4.09 - $6.5 $166,683 - $264,901	40,754 Added 2.78%	1,506,456 $6.25 Million
Q2 2022 Jul 29, 2022	BUY	$3.01 - $5.22 $523,128 - $907,220	173,797 Added 13.45%	1,465,702 $5.89 Million
Q1 2022 Apr 29, 2022	BUY	$4.83 - $7.35 $1.13 Million - $1.72 Million	234,178 Added 22.14%	1,291,905 $6.4 Million
Q4 2021 Feb 02, 2022	BUY	$6.16 - $12.07 $1.28 Million - $2.51 Million	208,127 Added 24.5%	1,057,727 $7.37 Million
Q3 2021 Oct 28, 2021	SELL	$9.7 - $14.34 $3.63 Million - $5.36 Million	-373,900 Reduced 30.56%	849,600 $8.5 Million
Q2 2021 Jul 29, 2021	SELL	$13.43 - $19.16 $958,230 - $1.37 Million	-71,350 Reduced 5.51%	1,223,500 $17.3 Million
Q1 2021 Apr 29, 2021	BUY	$15.82 - $22.11 $1.65 Million - $2.3 Million	104,147 Added 8.75%	1,294,850 $21.2 Million
Q4 2020 Jan 29, 2021	BUY	$7.91 - $22.95 $9.42 Million - $27.3 Million	1,190,703 New	1,190,703 $24.6 Million

Others Institutions Holding OCUL

# of Institutions

207

Shares Held

135M

Call Options Held

426K

Put Options Held

119K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $617M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Account

Emerald Advisers, LLC Ocular Therapeutix, Inc Transaction History